1. Home
  2. ILMN vs BEKE Comparison

ILMN vs BEKE Comparison

Compare ILMN & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • BEKE
  • Stock Information
  • Founded
  • ILMN 1998
  • BEKE 2001
  • Country
  • ILMN United States
  • BEKE China
  • Employees
  • ILMN N/A
  • BEKE N/A
  • Industry
  • ILMN Medical Specialities
  • BEKE Real Estate
  • Sector
  • ILMN Health Care
  • BEKE Finance
  • Exchange
  • ILMN Nasdaq
  • BEKE Nasdaq
  • Market Cap
  • ILMN 23.6B
  • BEKE 24.7B
  • IPO Year
  • ILMN 2000
  • BEKE 2020
  • Fundamental
  • Price
  • ILMN $134.96
  • BEKE $18.50
  • Analyst Decision
  • ILMN Buy
  • BEKE Strong Buy
  • Analyst Count
  • ILMN 17
  • BEKE 4
  • Target Price
  • ILMN $163.12
  • BEKE $25.97
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • BEKE 6.3M
  • Earning Date
  • ILMN 02-06-2025
  • BEKE 11-21-2024
  • Dividend Yield
  • ILMN N/A
  • BEKE 1.90%
  • EPS Growth
  • ILMN N/A
  • BEKE N/A
  • EPS
  • ILMN N/A
  • BEKE 0.50
  • Revenue
  • ILMN $4,390,000,000.00
  • BEKE $11,766,571,657.00
  • Revenue This Year
  • ILMN N/A
  • BEKE $13.86
  • Revenue Next Year
  • ILMN $4.05
  • BEKE $11.10
  • P/E Ratio
  • ILMN N/A
  • BEKE $36.70
  • Revenue Growth
  • ILMN N/A
  • BEKE 11.06
  • 52 Week Low
  • ILMN $97.36
  • BEKE $12.44
  • 52 Week High
  • ILMN $156.66
  • BEKE $26.05
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 40.09
  • BEKE 41.90
  • Support Level
  • ILMN $130.31
  • BEKE $17.89
  • Resistance Level
  • ILMN $137.69
  • BEKE $18.84
  • Average True Range (ATR)
  • ILMN 5.13
  • BEKE 0.70
  • MACD
  • ILMN -1.03
  • BEKE -0.07
  • Stochastic Oscillator
  • ILMN 21.69
  • BEKE 13.23

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2023, Beike's cofounders collectively control the company, while Tencent and its affiliates share 8% of voting power.

Share on Social Networks: